June 4, 2000 |
The suffering persisted for more than two years. Initially, there were four known victims. Then 21. Then 33. Finally, 63 confirmed fatalities. All the while, federal authorities watched, waited and hoped the deaths would stop. It was not until a disparate collection of physicians inside the U.S. Food and Drug Administration waged a remarkable revolt that the agency was forced to reverse course.
June 10, 1998 |
The fatalities ranged from the oldest man, an 80-year-old who collapsed suddenly in the middle of having sex, to the youngest, a 48-year-old, who experienced chest pains while having sex and later died in a hospital emergency room.
September 16, 1997 |
Two controversial diet drugs were removed from the market Monday after new evidence linked them to potentially serious heart valve problems, effectively ending the commonly known fen-phen combination that had been popular among those seeking to shed pounds. The Food and Drug Administration requested the withdrawal of the drugs fenfluramine, sold as Pondimin, and dexfenfluramine, sold as Redux.
CALIFORNIA | LOCAL
August 26, 1991 |
The federal Food and Drug Administration is warning that a supposed aphrodisiac distributed by a Sherman Oaks company is suspected of having caused the seizures that stopped the heart of a Virginia man. The capsules, which come in a box labeled "Spanish Fly Pills, Legendary Sex Exciter," are distributed by a company listed on the box as Pleasure Products. The address given is a post office box in Sherman Oaks.
June 18, 1993 |
Federal Food and Drug Administration chief David A. Kessler said Thursday that investigators have found no evidence to support suggestions that syringes were placed in Pepsi cans as part of a nationwide tampering scheme. There have been dozens of reports from 23 states that needles have been found in Pepsi cans, and at least six people have been arrested for allegedly filing false claims.
November 2, 2000 |
In the drug's first eight months on the market, five people who took it died. Several others underwent bowel surgeries--one had a colon removed. A total of 49 patients developed ischemic colitis, a potentially life-threatening complication. As a result, the Food and Drug Administration is now "reevaluating" the safety of Lotronex, a drug intended to treat women with a nonfatal disorder, irritable bowel syndrome.